Justice in Health Research: What is the role of evidence-based medicine?

Perspectives in Biology and Medicine

Volumn 52, Issue 2, 2009, Pages 188-202

  Rogers, Wendy ^a   Ballantyne, Angela ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; EVIDENCE BASED MEDICINE; HUMAN; JUSTICE; MEDICAL RESEARCH; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW; ARTICLE; ETHICS; HEALTH SERVICES RESEARCH; PUBLISHING; RESEARCH SUBJECT;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMANS; PUBLISHING; RESEARCH SUBJECTS;

EID: 67650684254     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. American Heart Association (AHA). 2006. Heart disease and stroke statistics: 2006 update. Dallas: AHA. http://www.dsf.health.state.pa.us/health/ lib/health/epht/heart-disease-and-stroke-stats-2006-update.pdf.
2. Ashiya,M., and A. Jindal. 2007.Medical Research and Development Treaty:A new r&d framework. Icfai J Syst Manag 5(1):23-31. http://ssrn.com/abstract= 1080727.
3. Ballantyne,A. J., andW.A.Rogers. 2008. Fair inclusion of men and women in Australian clinical research:Views from ethics committee chairs. Med J Aust 188(11):653-656
4. Brase,T. 2005. How technocrats are taking over the practice of medicine:A wake-up call to the American people. Policy report. St Paul, MN: Citizens' Council on Health Care. http://www.cchconline.org/pdfreport/.
5. Buetow, S., et al. 2006.Taking stock of evidence-based medicine: Opportunities for its continuing evolution. J Eval Clin Pract 12(4):399-404. (Pubitemid 44126787)
6. Burke,M. and Matlin S. (eds.), 2008.Monitoring Financial Flows for Health Research 2008. Geneva: Global Forum for Health Research. http://www. globalforumhealth.org/ filesupld/MFF08/MonitoringFinancialFlows2008.pdf.
7. Daniels, N. 1985. Just health care. Cambridge: Cambridge Univ. Press.
8. DeVries,R., andT. Lemmens. 2006.The social and cultural shaping of medical evidence: Case studies from pharmaceutical research and obstetric science. Soc Sci Med 62(11): 2694-2706
9. Drazen, J.M., and G. D. Curfman. 2002. Financial associations of authors. N Engl J Med 346(24):1901-1902
10. Dresser, R. 1992.Wanted: Single, white male for medical research. Hastings Cent Rep 22(1):24-30.
11. Elliott, C. 2004. Pharma goes to the laundry. Hastings Cent Rep 34(5):18-23.
12. Elliott, C. 2008. Guinea-pigging:Healthy human subjects for drug safety trials are in demand. But is it a living? NewYorker (Jan. 7):36-41.
13. Evidence Based MedicineWorking Group (EBMWG). 1992. Evidence based medicine: A new approach to teaching the practice of medicine. JAMA 268:2420-2425
14. Ferguson, P. R. 2002. Selecting participants when testing new drugs: the implications of age and gender discrimination. Med Leg J 70:130-134
15. Goodman, K. 2003. Ethics and evidence-based medicine: Fallibility and responsibility in clinical science. Cambridge: Cambridge Univ. Press.
16. Government Accountability Office (GAO). 1990.National Institutes of Health: problems in implementing policy on women in study populations. GAO testimony (GAO/THRD- 90-38). http://archive.gao.gov/d48t13/141859.pdf.
17. Harris, H. 2002. Factories of death: Japanese biological warfare, 1932-1945, and the American cover-up. NewYork: Routledge.
18. Healy,D., and D. Cattell. 2003. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry 183:22-27.
19. Hope,T. 1996. Evidence-based patient choice. London: King's Fund.
20. Hutchins, L. F., et al. 1999. Under representation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061-2067 (Pubitemid 30035956)
21. International Committee of Medical Journal Editors (ICMJE). 2005. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. http://www.icmje.org/clin-trial.pdf.
22. Jenicek,M. 2006. Evidence-based medicine: Fifteen years later.Golem the good, the bad, and the ugly in need of a review? Med Sci Monit 12(11):RA241-51.
23. Johnston, J., and A. A.Wasunna. 2007. Patents, biomedical research, and treatments: Examining concerns, canvassing solutions. Hastings Cent Rep 37(1):S1-S36. http:// www.thehastingscenter.org/Publications/SpecialReports/ Detail.aspx?id=1340.
24. Laing, C., et al. 2007. Clinical trial registration: Looking back and moving ahead.N Engl J Med 356(26):2734-2736 (Pubitemid 47001046)
25. Lee, P., and D. Paxman. 1997. Reinventing public health. Annu Rev Pub Health 18:1-35.
26. London, A. J. 2005. Justice and the human development approach to international research. Hastings Cent Rep 35(1):24-37. (Pubitemid 40712162)
27. Lurie, P., et al. 2006. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. JAMA 295(16): 1921-1928
28. Merkatz,R.B., et al. 1993.Women in clinical trials of new drugs: A change in Food and Drug Administration policy.TheWorking Group onWomen in ClinicalTrials.N Engl J Med 329(4):292-296
29. Mirowski, P., and R.Van Hom. 2005.The contract research organization and the commercialization of scientific research. Soc Stud Sci 35(4):503-548 (Pubitemid 41186379)
30. Murthy,V.H.,H.M. Krumholz, and C. P.Gross. 2004. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291(22):2720-2726 (Pubitemid 38725421)
31. Petryna, A. 2007. Clinical trials offshored: On private sector science and public health. BioSocieties 2:21-40.
32. Pogge, T. 2009. The health impact fund: Boosting pharmaceutical innovation without obstructing free access. Camb Q Healthc Ethics 18:78-86.
33. Quigley, D. 2006. A review of improved ethical practices in environmental and public health research: Case examples from native communities. Health Educ Behav 33(2): 130-147
34. Rogers.W.A. 2002. Evidence-based medicine in practice: Limiting or facilitating patient choice? Health Expect 5:95-103. (Pubitemid 34591870)
35. Rogers,W.A. 2004a. Evidence-based medicine and justice:A framework for looking at the impact of EBM on vulnerable or disadvantaged groups. J Med Ethics 30:141-145
36. Rogers,W.A. 2004b. Evidence-based medicine and women: Do the principles and practice of EBM further women's health? Bioethics 18(1):62-83.
37. Rogers,W. A., and A. J. Ballantyne. 2008. Exclusion of women from clinical research: Myth or reality? Mayo Clin Proc 83(5):536-542
38. Sismondo, S. 2008. How pharmaceutical industry funding affects trial outcomes: Causal structures and responses. Soc Sci Med 66(9):1909-1914
39. Strauss S and Jones G. 2004.What has evidence based medicine done for us? BMJ 329: 987-988 (Pubitemid 39486244)
40. Ter Muelen,R., et al., eds. 2005. Evidence based practice in medicine and health care:A discussion of the ethical issues. Berlin: Springer-Verlag.
41. Trouiller, P., et al. 2002.Drug development for neglected diseases:A deficient market and a public-health policy failure. Lancet 359(9324):2188-2194 (Pubitemid 34694030)
42. Wenger, N. K. 2006. Coronary heart disease in women: Highlights of the past 2 years. Stepping stones, milestones and obstructing boulders. Nat Clin Pract Cardiovasc Med 3(4):194-202.